Show/Hide Menu

MorphoSys as a partner

You are here

With its longstanding expertise in antibody engineering, proven development capabilities and leading technologies, MorphoSys is a qualified partner in the industry for drug discovery and the development of biologics.

MorphoSys’s worldwide partnering track record spans a wide range of agreements, from collaborations with academia and innovative biopharmaceutical start-ups to drug discovery alliances with several of the largest pharmaceutical companies like Novartis, Roche, Johnson & Johnson/Janssen, Pfizer, Bayer and Boehringer Ingelheim. For the further development and commercialization of our proprietary clinical-stage programs we have been able to attract GlaxoSmithKline. These productive partnerships have resulted in one of the largest therapeutic antibody pipelines to date.

MorphoSys is dedicated to becoming a fully integrated biopharmaceutical company including late-stage clinical development and marketing/co-promotion of its own drugs. With our goal of engineering the medicines of tomorrow in mind, we are always interested in new collaborations with innovative, science-driven organizations and academic institutions.

MorphoSys has a proven track record of successful alliances including research and development agreements with a number of leading pharmaceutical and biotechnology companies.

Meet us at the following conferences

Mon
09
'15
Mar

BIO-Europe Spring

Paris, France
Mon-Thu
04-07
'15
May
May

PEGS Boston

Boston, USA
Sat-Tue
06-09
'15
Jun
Jun

BIO Convention

San Francisco, USA
Mon
15
'15
Jun

BIO Convention

Philadelphia, USA
Wed-Fri
16-18
'15
Sep
Sep

12th International Pharma Licensing Symposium

Berlin, Germany
Mon-Wed
02-04
'15
Nov
Nov

BIO-Europe 2015

Munich, Germany
Mon-Tue
16-17
'15
Nov
Nov

4th Oncology Partnering & Deal-making Conference

San Francisco, CA, USA
Mon-Thu
11-14
'16
Jan
Jan

J.P. Morgan 34th Annual Healthcare Conference

San Francisco, USA
Mon-Wed
04-06
'16
Apr
Apr

BIO-Europe Spring 2016

Stockholm, Sweden
Mon-Wed
07-09
'16
Nov
Nov

Bio-Europe

Cologne, Germany
Sat-Tue
03-06
'16
Dec
Dec

ASH Annual Meeting 2016

San Diego, CA, USA
Mon-Fri
09-13
'17
Jan
Jan

35th JPMorgan Conference

San Francisco, CA, USA

Business Development

Dr. Barbara Krebs-Pohl

Senior Vice President, Head of Business Development

Phone: +49 (0)89 89927 453

Fax: +49 (0)89 89927 5453

Email Contact

Dr. Konstantin Petropoulos

Director Business Development

Phone: +49 (0)89 89927 453

Fax: +49 (0)89 89927 5453

Email Contact

Innovation Capital

Sascha Alilovic

Vice President Corporate Finance and Corporate Development

Phone: +49 (0)89 89927 478

Email Contact

Dr. Peter Ruile

Senior Director Corporate Finance and Corporate Development

Phone: +49 (0)89 89927 478

Email Contact

Christoph von Plotho

Senior Manager Corporate Finance and Corporate Development

Phone: +49 (0)89 89927 478

Email Contact

Please note: MorphoSys has a specific procedure for receiving and processing confidential or proprietary information from external sources. Please contact us to obtain the details of this procedure before sending any such information. For that reason, all unsolicited submissions of any kind will be treated as non-confidential and non-proprietary and MorphoSys may freely use any ideas, inventions or anything else contained in your submission.